Participating Faculty

Supplements and Featured Publications, The Great Debate Part II: Should Managed Care Rely on Cost Sharing to Manage Big-ticket Biologics?, Volume 12, Issue 6 Suppl

The American Journal of Managed Care

This supplement to is based partly on a moderated sessionheld at the annual meeting of the Academy of Managed Care Pharmacy, October 7, 2005, in Nashville,Tennessee. This supplement has been prepared with writing and editorial services of the The ZitterGroup. It has been peer reviewed by an expert in the field.

Faculty

  • Diana I. Brixner, RPh, PhDAssociate Professor and Chair Department of Pharmacotherapy Executive Director Pharmacotherapy Outcomes Research Center University of Utah College of Pharmacy Salt Lake City, Utah
  • Leslie Fish, RPh, PharmDDirector of Pharmacy Services Fallon Community Health Plan Worchester, Massachusetts
  • Wayne M. Lednar, MD, PhDVice President Chief Medical Director Eastman Kodak Company Rochester, New York
  • Mark Zitter, MBACEO The Zitter Group Millburn, New Jersey

Faculty Disclosures

Diana I. Brixner, RPh, PhD, reports that she (nor does any immediate family member) does nothave a vested interest in or affiliation with any corporate organization offering financial supportor grant monies for this continuing education activity or any affiliation with an organizationwhose philosophy could potentially bias her involvement in this activity.

Leslie Fish, RPh, PharmD, reports that she (nor does any immediate family member) does nothave a vested interest in or affiliation with any corporate organization offering financial supportor grant monies for this continuing education activity or any affiliation with an organizationwhose philosophy could potentially bias her involvement in this activity.

Wayne M. Lednar, MD, PhD, reports that he (nor does any immediate family member) does nothave a vested interest in or affiliation with any corporate organization offering financial supportor grant monies for this continuing education activity or any affiliation with an organizationwhose philosophy could potentially bias his involvement in this activity.

Mark Zitter, MBA, reports that he has (or an immediate family member has) a vested interest inor affiliation with a corporate organization offering financial support or grant monies for this continuingeducation activity or with an organization that has a specific interest in the therapeuticareas under discussion as follows: his company, The Zitter Group, sells services or products tomost major biotechnology firms. He is also a consultant for Genentech.

The American Journal of Managed Care,

Signed disclosures are on file at the offices of Jamesburg,New Jersey.

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agentsthat are not indicated by the US Food and Drug Administration. The University of Utah Collegeof Pharmacy and the University of Utah School of Medicine do not recommend the use of anyagent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarilyrepresent the views of the University of Utah College of Pharmacy or the University of Utah Schoolof Medicine. Please refer to the official prescribing information for each product for discussion ofapproved indications, contraindications, and warnings.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhancepatient outcomes and their own professional development. The information presented in thisactivity is not meant to serve as a guideline for patient management. Any procedures, medications,or other courses of diagnosis or treatment discussed or suggested in this activity should not beused by clinicians without evaluation of their patients' conditions and possible contraindicationson dangers in use, review of any applicable manufacturer's product information, and comparisonwith recommendations of other authorities.

Americans with Disabilities Act (ADA): The University of Utah College of Pharmacy and theUniversity of Utah School of Medicine complies with the ADA by providing qualified individualswith disabilities access to University programs, services, and activities. A request for accommodationcan be made by calling (801) 483-3039. Reasonable prior notice is required.